Exhibiting at the 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO 2026)

ProteoBridge Co., Ltd. is pleased to announce our participation in the 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO 2026), where we will be exhibiting in collaboration with Fushimi Pharmaceutical Co., Ltd.

This year’s meeting is held under the theme “Medical Oncologists for Cancer Patients,” highlighting the vital role of oncology professionals in advancing patient-centered care.

During the event, we will showcase our research testing services, with a focus on the A-Cube® platform.We are also excited to introduce our new offering, A-Cube® Light, for the first time.

Event Overview

・Event: 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO 2026)

・Date : March 26th(thu.)-28th(sat.), 2026

・Venue: PACIFICO Yokohama North, Exhibition Hall D (Yokohama, Japan)

・Booth: Exhibition Hall D, Booth No. 30

・Congress President: Dr. Kenji Tamura

(Shimane University Hospital, Department of Oncology / Advanced Cancer Center)

What We Will Showcase

-Research Testing Services

・A-Cube®

・A-Cube® Light (New)

・A-Cube® Beta Version

Autoantibody detection panel for Sjögren’s syndrome

Autoantibody detection panel for paraneoplastic neurological syndromes

・HuPEX® comprehensive protein array analysis service

-Case Studies

・Applications and use cases of our proprietary array technologies

Event Highlights

Please visit our booth No.30.

We look forward to meeting you in person.